PROCEPT BioRobotics PRCT Cash Flow Statement (2020-2026)

NASDAQ PRCT
$23.80 +0.29 (+1.23%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

PROCEPT BioRobotics Quarterly Cash Flow Statement

Periods 25 quarters
Latest Sep 2026

PROCEPT BioRobotics reported cash from operations of -$8.98M and free cash flow of -$9.65M for the quarter ended Sep 2026, down 35.4% year over year. This cash flow statement covers 25 quarters of results from Sep 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-18.35M-17.19M-19.18M-22.61M-28.17M-28.48M-25.29M-24.62M-27.50M-25.96M-25.63M-20.97M-18.86M-24.74M-19.58M-21.41M-29.85M-31.64M-26.86M-26.52M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.76M0.76M0.72M0.70M0.66M0.79M0.64M1.05M1.32M1.18M1.27M1.33M1.45M1.48M1.59M1.62M1.71M1.74M1.99M2.54M
Share-based CompensationStock Comp.
1.50M1.55M2.68M3.22M2.89M3.72M5.10M5.33M4.98M6.26M7.99M8.51M9.09M10.11M12.16M14.49M10.84M13.07M14.53M15.08M
Gains from Investment SecuritiesGains Investment
0.02M-0.04M
Asset Writedowns and ImpairmentWritedown
0.11M0.09M-0.03M0.23M0.19M0.58M0.91M0.38M0.60M0.30M0.60M0.53M-0.86M0.20M0.41M0.55M
Other non-cash itemsOther Non-Cash
0.01M0.04M0.04M0.04M3.47M0.03M0.03M0.03M0.03M0.03M0.03M0.51M0.38M0.33M-0.19M0.30M-0.07M0.57M0.57M-0.70M
Change in Working Capital
Change in ReceivablesChange Receivables
-1.89M2.53M3.90M1.95M2.43M5.37M12.53M1.45M13.75M7.71M2.84M10.59M14.83M-3.93M2.71M4.35M-2.23M13.32M11.63M-2.03M
Change in InventoryChange Inventory
2.54M-0.52M1.20M8.82M5.75M10.14M3.29M-0.49M-3.19M1.49M2.79M7.16M5.80M6.28M4.79M-0.57M4.00M7.03M-0.20M3.46M
Change in Account PayablesChange Payables
-1.55M0.45M0.50M3.30M-0.28M2.23M0.01M-2.32M5.88M-2.31M0.34M5.19M-5.38M3.75M-2.25M-0.79M5.93M1.54M-2.85M1.52M
Change in Accrued ExpensesChange Accrued Exp.
1.03M-1.89M2.39M3.31M3.16M-6.04M2.54M3.32M3.62M-5.42M3.41M3.95M2.70M-6.56M1.31M5.46M1.38M-4.69M1.96M5.53M
Change in Other Operating AssetsOther Assets Change
2.03M-0.18M0.01M0.37M1.73M-1.93M-0.42M0.53M1.65M0.92M-0.86M1.48M3.30M-0.18M0.26M2.57M1.35M-0.74M-0.40M4.31M
Change in Other Operating LiabilitiesOther Liabilities Change
1.95M-0.27M0.76M0.83M3.50M4.65M3.98M-0.66M-0.82M4.11M0.78M1.58M1.61M0.63M1.16M-0.39M3.78M0.81M2.15M-1.14M
Other Working Capital ChangesOther WC Changes
-0.08M-0.09M0.75M0.46M1.77M6.58M4.40M-1.18M-2.47M3.19M1.63M0.10M-1.69M0.81M0.90M-2.96M2.43M1.54M2.54M-5.45M
Cash from OperationsCash from Ops.
-16.48M-18.23M-17.13M-19.85M-25.17M-35.93M-28.34M-18.94M-24.79M-32.29M-15.74M-18.80M-32.39M-16.98M-15.04M-6.64M-10.33M-38.13M-19.25M-8.99M
Investing Activities
Capital ExpendituresCapex
0.33M0.06M0.22M1.51M0.87M5.34M5.37M5.78M8.72M1.95M1.04M0.25M1.17M1.84M2.80M2.87M1.85M2.91M2.95M0.67M
Change in Property, Plant and EquipmentChange in PP&E
-0.33M-0.06M-0.22M-1.51M-0.87M-5.34M-5.37M-5.78M-8.72M-1.95M-1.04M-0.25M-1.17M-1.84M-2.80M-2.87M-1.85M-2.91M-2.95M-0.67M
Other Investing Activities (as filed)Other investing (as filed)
3.81M0.00M3.82M-0.78M3.04M3.04M3.04M
Cash from Investing ActivitiesCash from Investing
-0.33M-0.06M-0.22M-1.51M-0.87M-5.34M-5.37M-5.78M-8.72M-1.95M-1.04M-0.25M-1.17M-1.84M-2.80M-2.87M-1.85M-2.91M-2.95M-0.67M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-2.12M0.00M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-2.12M0.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
-2.12M0.00M
Change in Capital Stock
Common Stock IssuedStock Issued
0.64M1.29M2.86M0.78M1.49M0.38M2.43M162.12M2.87M2.59M3.17M1.72M172.65M1.30M4.38M1.08M4.44M0.22M4.50M0.10M
Net Shares Issued and RepurchasedNet Shares Issued
0.64M1.29M2.86M0.78M1.49M0.38M2.43M162.12M2.87M2.59M3.17M1.72M172.65M1.30M4.38M1.08M4.44M0.22M4.50M0.10M
Net Equity Issued and RepurchasedNet Equity Issued
0.64M1.29M2.86M0.78M1.49M0.38M2.43M162.12M2.87M2.59M3.17M1.72M172.65M1.30M4.38M1.08M4.44M0.22M4.50M0.10M
Cash from Financing ActivitiesCash from Financing
0.64M1.29M2.86M0.78M-1.32M0.38M2.43M162.12M2.87M2.59M5.30M1.72M170.53M1.30M4.38M1.08M4.44M0.22M4.50M0.10M
Additional items
Exchange Rate EffectFX Effect
-0.02M-0.01M-0.04M-0.04M-0.02M0.01M
Change in Cash
-16.16M-17.00M-14.48M-20.59M-27.36M-40.89M-31.28M137.40M-30.64M-31.65M-11.48M-17.33M136.96M-17.52M-13.49M-8.44M-7.78M-40.86M-17.73M-9.55M
Beginning Cash Balance
100.91M305.10M305.10M305.10M305.10M225.67M225.67M225.67M225.67M260.26M260.26M260.26M260.26M336.76M336.76M336.76M336.76M289.54M289.54M289.54M
Ending Cash Balance
305.10M288.10M273.62M253.03M225.67M184.79M153.51M290.90M260.26M228.61M217.13M199.80M336.76M319.25M305.76M297.32M289.54M248.68M230.95M221.41M
Free Cash FlowFCF
-16.81M-18.29M-17.34M-21.37M-26.04M-41.27M-33.71M-24.72M-33.51M-34.23M-16.78M-19.05M-33.57M-18.82M-17.85M-9.50M-12.18M-41.04M-22.20M-9.65M
Net Cash FlowNCF
-16.16M-17.00M-14.48M-20.59M-27.36M-40.89M-31.28M137.40M-30.64M-31.65M-11.48M-17.33M136.96M-17.52M-13.47M-8.43M-7.74M-40.82M-17.71M-9.55M
Interest Paid
1.18M1.17M1.20M1.20M0.72M1.12M0.94M0.99M1.00M1.00M1.03M1.01M0.92M0.89M0.87M0.88M0.83M0.80M0.79M0.80M
Income Taxes PaidTaxes Paid
0.19M

PROCEPT BioRobotics Cash Flow Statement API

Pull PROCEPT BioRobotics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PRCT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY